Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach
Authors
Keywords
-
Journal
DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-02
DOI
10.1007/s40265-020-01309-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk profiling for a refractory course of rheumatoid arthritis
- (2019) Manuel Bécède et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
- (2019) Frances Humby et al. ANNALS OF THE RHEUMATIC DISEASES
- Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients
- (2019) Philip D H Hamann et al. RHEUMATOLOGY
- Predictors of fatigue in rheumatoid arthritis
- (2019) Katie L Druce et al. RHEUMATOLOGY
- Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
- (2019) Gloria Lliso-Ribera et al. ANNALS OF THE RHEUMATIC DISEASES
- Levels of CXCL13 and sICAM-1 correlate with disease activity score in patients with rheumatoid arthritis treated with tocilizumab
- (2019) Katie Tuckwell et al. Advances in Rheumatology
- Overdiagnosis and overtreatment in rheumatology: a little caution is in order
- (2018) Robert B M Landewé ANNALS OF THE RHEUMATIC DISEASES
- Defining refractory rheumatoid arthritis
- (2018) Maya H Buch ANNALS OF THE RHEUMATIC DISEASES
- Secukinumab after anti-tumour necrosis factor-α therapy: a phase III study in active rheumatoid arthritis
- (2018) E Dokoupilová et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Response to ’Response to viewpoint ’Defining refractory rheumatoid arthritis' by Buch' by Roodenrijset al
- (2018) Maya H Buch ANNALS OF THE RHEUMATIC DISEASES
- Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey
- (2018) Nadia M T Roodenrijs et al. ANNALS OF THE RHEUMATIC DISEASES
- Pathogenic stromal cells as therapeutic targets in joint inflammation
- (2018) Stephanie G. Dakin et al. Nature Reviews Rheumatology
- Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment
- (2017) Joachim R. Kalden et al. Nature Reviews Rheumatology
- Synovial tissue research: a state-of-the-art review
- (2017) Carl Orr et al. Nature Reviews Rheumatology
- Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
- (2017) Ernest H S Choy et al. RHEUMATOLOGY
- Let’s not fool ourselves. In RA, the ACR/EULAR remission criteria are not perfect!
- (2016) Kenneth F Baker et al. ANNALS OF THE RHEUMATIC DISEASES
- Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis
- (2016) Mari Kihara et al. CLINICAL RHEUMATOLOGY
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discordance between the predictors of clinical and imaging remission in patients with early rheumatoid arthritis in clinical practice: implications for the use of ultrasound within a treatment-to-target strategy
- (2016) Sarah C. Horton et al. RHEUMATOLOGY
- Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis
- (2016) J. E. Gottenberg et al. Arthritis & Rheumatology
- Cytokines in rheumatoid arthritis — shaping the immunological landscape
- (2015) Iain B. McInnes et al. Nature Reviews Rheumatology
- Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort
- (2014) B Combe et al. ANNALS OF THE RHEUMATIC DISEASES
- Smoking and Rheumatoid Arthritis
- (2014) Kathleen Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Genetic and epigenetic predictors of responsiveness to treatment in RA
- (2014) Darren Plant et al. Nature Reviews Rheumatology
- Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
- (2014) Glynn Dennis et al. ARTHRITIS RESEARCH & THERAPY
- Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
- (2014) Helga Radner et al. ARTHRITIS RESEARCH & THERAPY
- Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients
- (2013) S Kelly et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
- (2013) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of Monoclonal Antibodies Against Tumor Necrosis Factor Used in Chronic Immune-Mediated Inflammatory Conditions
- (2013) Jose Ramon Maneiro et al. JAMA Internal Medicine
- The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register
- (2012) Jennifer H Humphreys et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of Rheumatoid Arthritis Risk Alleles with Response to Anti-TNF Biologics: Results from the CORRONA Registry and Meta-analysis
- (2012) Dimitrios A. Pappas et al. INFLAMMATION
- Interferon type I signature may predict non response upon rituximab in rheumatoid arthritis patients
- (2012) Hennie G Raterman et al. ARTHRITIS RESEARCH & THERAPY
- Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
- (2011) M. H. Buch et al. ANNALS OF THE RHEUMATIC DISEASES
- Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
- (2011) K. Chatzidionysiou et al. ANNALS OF THE RHEUMATIC DISEASES
- Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients
- (2010) Rogier M. Thurlings et al. ARTHRITIS AND RHEUMATISM
- PTPRCrheumatoid arthritis risk allele is also associated with response to anti-TNF therapy
- (2010) Jing Cui et al. ARTHRITIS AND RHEUMATISM
- Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008
- (2010) K. L. Hyrich et al. RHEUMATOLOGY
- Anakinra for Rheumatoid Arthritis: A Systematic Review
- (2009) M. MERTENS et al. JOURNAL OF RHEUMATOLOGY
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
- (2009) Sarah L. Gaffen Current Rheumatology Reports
- Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study
- (2008) M H Buch et al. ANNALS OF THE RHEUMATIC DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation